HTG, Thermo Fisher Enter Development and Supply Agreement

HTG Molecular Diagnostics has entered into a development and supply agreement with Thermo Fisher Scientific.

Under the agreement, HTG will develop in-vitro diagnostic tests for use with Thermo Fisher’s Ion PGM Dc System for the detection of cancer and genetic disorders.

“We believe the combination of HTG EdgeSeq chemistry and automation platform with the Ion Torrent next-generation sequencing platform is a great solution for clinical sequencing workflows in molecular diagnostic laboratories,” said HTG CEO TJ Johnson. — Anisa Jibrell